byiShook Opinion
Sep 16, 2024 - 11:25
Ascendis Pharma stock rocketed Monday on promising test results for a growth treatment that could rival BioMarin's approved drug, Voxzogo. The post Ascendis Rockets — And Hammers BioMarin — On New Results For Growth Drug appeared first on Investor's Business Daily.
Ascendis Pharma stock rocketed Monday on promising test results for a growth treatment that could rival BioMarin's approved drug, Voxzogo.
The post Ascendis Rockets â And Hammers BioMarin â On New Results For Growth Drug appeared first on Investor's Business Daily.